Furthermore, we uncover that PIK3CD overexpression in GC may be induced by the activation of the pro‐inflammatory IL2‐JAK3‐STAT5 signaling axis and PIK3CD may serve as an effective therapeutic target for GC treatment. Here, JAK3 is linked to gastric cancer.